A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
UAE to strengthen defence, space and health sectors, says H.H. Sheikh Mohammed
UAE responds to further missile, drone threats on Sunday
16 ballistic missiles, 42 drones intercepted on Sunday
Dubai Police issue 720 certificates for weather-affected vehicles
Gargash: Political solution needs guarantees against repeat Iranian attacks
H.H. Sheikh Mohammed congratulates Dubai World Cup winner
Sheikh Abdullah discusses impact of Iranian attacks with global partners
Dubai opens 13 new cycling tracks under 162km RTA expansion plan
